SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-023137
Filing Date
2024-07-22
Accepted
2024-07-22 09:25:05
Documents
18
Period of Report
2024-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20240718_8k.htm   iXBRL 8-K 62014
2 EXHIBIT 3.1 ex_700461.htm EX-3.1 341711
3 EXHIBIT 4.1 ex_700462.htm EX-4.1 199033
4 EXHIBIT 10.1 ex_700463.htm EX-10.1 327345
5 EXHIBIT 10.2 ex_700464.htm EX-10.2 197865
  Complete submission text file 0001437749-24-023137.txt   1512500

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20240718.xsd EX-101.SCH 3409
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240718_def.xml EX-101.DEF 11804
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240718_lab.xml EX-101.LAB 15848
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240718_pre.xml EX-101.PRE 12019
20 EXTRACTED XBRL INSTANCE DOCUMENT wint20240718_8k_htm.xml XML 2946
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 241129962
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)